Project Grant R34CA300990
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $259K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94305, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Children's Hospital of Philadelphia a $749,133 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) effective June 1, 2026, through May 31, 2031. This award funds the Evaluating and Implementing a Decision Support Intervention (DECIDES) for Adolescents and Young Adults Newly Diagnosed with Cancer project, which develops and tests a digital decision-support tool designed to enhance shared...
- Federal Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a $584,521 Project Grant on August 8, 2025, under the Cancer Treatment Research program (CFDA 93.395) to investigate subclonal determinants of radiation response in soft tissue sarcomas. The research will deliver three primary products: (1) identification and validation of epigenetic changes, including DNA methylation and chromatin accessibility alterations, that confer radioresistance to...
- Federal Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a Project Grant of $137,266 under the Cancer Research Manpower program (CFDA 93.398) for the period July 1, 2026 through June 30, 2028. This award supports comprehensive profiling research focused on developing personalized interventions for T-cell lymphoma (TCL), a malignancy with high relapse rates and poor prognosis. The project delivers three integrated research components: (1) development...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Leland Stanford Junior University a $635,340 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) on May 4, 2026, with completion targeted for April 30, 2031. This grant funds functional genomic research to dissect lung cancer mechanisms through an integrated approach combining genetically engineered mouse models, multiplexed CRISPR-based genome editing, and tumor barcoding technologies. The...
- Federal Project Grant Award Summary Children's Hospital Los Angeles received an $8.47 million Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded September 10, 2025, with performance through August 31, 2029. The award funds a patient navigation intervention designed to improve transition success among multiply disadvantaged young adult survivors of childhood cancer (CCS). The project addresses a critical gap in...
- Federal Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a Project Grant of $642,732 under the Cancer Cause and Prevention Research program (CFDA 93.393) beginning August 1, 2025, with a completion date of July 31, 2030. The award supports research to unravel heterogeneity in endometrial cancer through integrated single-cell genotype-phenotype mapping. The project addresses the critical need to refine molecular classification, improve...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Leland Stanford Junior University a Project Grant of $158,499 under the Cancer Research Manpower program (CFDA 93.398) for research investigating the role of CDKN2A in lung adenocarcinoma metastasis. The award, obligated on May 15, 2026, with a completion date of April 30, 2028, supports research utilizing CRISPR-Cas9 somatic genome editing and tumor barcoding to develop novel metastasis assay models in...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded Sloan-Kettering Institute for Cancer Research a $745,458 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) for the period July 1, 2026 through June 30, 2031. The award funds development and implementation of the PERSON Intervention, an innovative digital health solution designed to facilitate person-centered communication between oncology patients and clinicians. The intervention...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Leland Stanford Junior University a Project Grant of $100,228.00 under the Cancer Research Manpower program (CFDA 93.398) to support biomedical research training and workforce development in cancer research. The award, obligated on December 1, 2026, with an ultimate completion date of June 30, 2029, funds research investigating the regulation of early breast cancer invasion by cancer-associated fibroblasts (CAFs). The...
- Federal Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a $368,294 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) for the period September 1, 2025 through August 31, 2028. This award supports the development of next-generation platforms for interrogating T cell receptor (TCR) specificity to identify and detect tumor antigens at the protein level. The project addresses a critical bottleneck in cancer...